Technology News and Research

RSS

Enzo Biochem to unveil data on AmpiProbe HCV assay at ESCMID meeting

Enzo Biochem Inc. announced today that the company will present for the first time peer-reviewed data on detection of hepatitis C virus (HCV) using its novel AmpiProbe technology platform, which provides low cost and high sensitivity real-time nucleic acid amplification assays.

9 Mar 2012

FDA clears Abbott's FreeStyle InsuLinx Blood Glucose Monitoring System

Abbott today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients.

8 Mar 2012

XMetA can control blood glucose levels in patients with diabetes

XOMA Corporation announced that its study of XMetA, the company's fully-human allosteric monoclonal antibody to the insulin receptor, is available online and will be published in the May issue of the American Diabetes Association's journal Diabetes.

8 Mar 2012

New precise 3D scanner provides image in 12 seconds

Reliable and highly accurate raw data is needed to use 3D images of a person or object, for example for body measurement. The VITUS smart body scanner from VITRONIC generates an accurate 3D image during a scan of only 12 seconds. VITRONIC will present the VITUS smart body scanner at the 3D Body Scanning Technologies Asian Workshop in Tokyo, Japan.

8 Mar 2012

£1.2 billion over five years to be saved with Telehealth roll out in UK

Telehealth or telecare in health may soon allow people with long term conditions like heart disease, diabetes and chronic obstructive pulmonary disorder (COPD) to manage their illness largely from home feel authorities.

8 Mar 2012

Bellicum raises $20M in Series B financing

Bellicum Pharmaceuticals, Inc. today announced that it has raised $20 million in a Series B financing. The funding will be used to advance its lead CaspaCIDe and DeCIDe programs through Phase 2 clinical development.

8 Mar 2012

First ever analysis of genetic variation between different regions of same tumour

Taking a sample from just one part of a tumour may not give a full picture of its 'genetic landscape', according to a landmark study published in the New England Journal of Medicine.

8 Mar 2012

M-FAST improves simulation education across the nursing schools

To secure a state-of-the-art education for tomorrow's nurses, Maryland's nurse educators must become masters of simulation technology. Faculty from 10 Maryland nursing schools have now learned how to incorporate simulation training in their teaching thanks to the Maryland Faculty Academy for Simulation Teaching in Nursing (M-FAST), held on January 9-13, 2012 at the Johns Hopkins University School of Nursing.

8 Mar 2012

Medtech acquires Camelot Healthcare Training Institute

Camelot Healthcare Training Institute, a post-secondary nursing and allied health care education provider in Central Florida, has been acquired by Medtech College. Camelot now joins the Medtech family of schools and will become Medtech College once appropriate state approvals have been obtained.

8 Mar 2012

Zalicus fourth quarter revenue decreases to $8.2 million

Zalicus Inc. today reported financial results for the fourth quarter and year ended December 31, 2011.

8 Mar 2012

NCGR to host eighth annual NMBIST symposium on March 22-23, 2012

The National Center for Genome Resources (NCGR) announced today that it will host the eighth annual New Mexico Bioinformatics, Science and Technology (NMBIST) symposium on March 22-23, 2012.

7 Mar 2012

Nuance enters definitive agreement to acquire Transcend

Nuance Communications, Inc. and Transcend Services, Inc. today announced a definitive agreement for Nuance to acquire Transcend, a leading provider of medical transcription and speech editing services, for approximately $300 million, net, in cash.

7 Mar 2012

Illumina launches new highly multiplexed cancer panel

Illumina today introduced the TruSeq Amplicon - Cancer Panel, a highly multiplexed panel that will allow researchers to accurately sequence hundreds of the most relevant cancer loci, even in difficult samples such as formalin-fixed, paraffin embedded (FFPE) tumor samples.

From Illumina, Inc. 7 Mar 2012

Study: Patients need greater access to their electronic medical data

Health care organizations need to do more to help patients realize the full benefits of electronic data from emerging health information exchange systems, according to a new study commissioned by Consumers Union that appears in the March 2012 Health Affairs.

7 Mar 2012

ERH wins PRI's 2012 Best Practices in Risk Management and Patient Safety Award

Physicians' Reciprocal Insurers (PRI), the second largest medical malpractice insurer in New York state, today presented Ellenville Regional Hospital with its 2012 Best Practices in Risk Management and Patient Safety Award.

7 Mar 2012

NeuroVista technology shows promise in detecting and predicting seizures

Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health.

7 Mar 2012

Methodist, UH to improve existing surgical training processes

Measure twice and cut once is a well-known phrase among surgeons, but this is not always what happens. To better prepare new surgeons for the operating room, University of Houston (UH) computer scientists are working with medical researchers at the Methodist Institute for Technology, Innovation and Education (MITIE) to improve existing training processes.

7 Mar 2012

Researchers reveal how melanoma develops resistance to Zelboraf

Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it. Now, researchers at UCLA's Jonsson Comprehensive Cancer Center have uncovered how an advanced form of melanoma gets around an inhibitor, Zelboraf, which targets the mutated BRAF gene.

7 Mar 2012

Altogen launches new pancreas-targeted in vivo RNAi transfection system

Altogen Biosystems announced the launch of its new pancreas-targeted in vivo RNAi transfection system in the company's popular in vivo delivery product line for use in laboratories and research facilities for development of new medicines and testing in cells and animals.

7 Mar 2012

Pharmspective releases first knowledge management application: ClearView

Pharmspective, LLC today announced the release of its first knowledge management application - ClearView - specifically developed to analyze provisions in the health care reform law and their impact on key pharma customer decision makers who influence product adoption.

7 Mar 2012